Protein inhibitor revives chemotherapy for ovarian patients

Researchers have discovered a way that may help ovarian cancer patients who no longer respond to conventional chemotherapy. In a new study, they describe how the inhibition of a protein, CHEK1, may be an effective element to incorporate into therapies for women with ovarian cancer.

Read the whole article on Science Daily

More from Science Daily